Literature DB >> 8941921

Macrophages and chronic renal allograft nephropathy.

B P Croker1, W L Clapp, A R Abu Shamat, B C Kone, J C Peterson.   

Abstract

In a previous study we demonstrated that macrophage infiltrates stained for thromboxane A synthase (TxAS) correlated inversely with renal function six months after biopsy. We propose that macrophage based inflammation is a cofactor leading to chronic allograft nephropathy. For this study we compared four indices of renal allograft nephropathy with renal survival. The Banff Score of Inflammatory Changes (BSI) is an index of acute inflammation. The Banff Chronic Index (BCI) and Chronic Allograft Damage Index (CADI) are indexes of chronic disease. The Macrophage Index (MI) is the same as the BSI applied only to macrophages. These indices were determined on renal allograft biopsies obtained because of delayed graft function within the first week of transplantation, and for increasing plasma creatinine levels after stable function. All four indices predicted renal survival in the post-biopsy interval. MI predicted renal survival for the entire transplant period. In addition, the presence of TxAS transcripts in the renal allografts was determined using a reverse transcription-polymerase chain reaction-based assay. This confirms previous observations of TxAS in the grafts. This study supports the hypothesis that macrophage derived inflammation is a cofactor for chronic allograft nephropathy.

Entities:  

Mesh:

Year:  1996        PMID: 8941921

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  8 in total

1.  CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.

Authors:  K S Kim; M D Denton; A Chandraker; A Knoflach; R Milord; A M Waaga; L A Turka; M E Russell; R Peach; M H Sayegh
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection.

Authors:  Anja Dankof; Maximilian Schmeding; Lars Morawietz; Raphaela Günther; Manfred G Krukemeyer; Birgit Rudolph; Martin Koch; Veit Krenn; Ulf Neumann
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

3.  Cell-cell contacts with epithelial cells modulate the phenotype of human macrophages.

Authors:  I Striz; A Slavcev; J Kalanin; M Jaresová; S I Rennard
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

4.  Alternatively activated macrophages in the pathogenesis of chronic kidney allograft injury.

Authors:  Yohei Ikezumi; Toshiaki Suzuki; Takeshi Yamada; Hiroya Hasegawa; Utako Kaneko; Masanori Hara; Toshio Yanagihara; David J Nikolic-Paterson; Akihiko Saitoh
Journal:  Pediatr Nephrol       Date:  2014-12-09       Impact factor: 3.714

Review 5.  The divergent roles of macrophages in solid organ transplantation.

Authors:  Sahar Salehi; Elaine F Reed
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

6.  Monocytes/macrophages in kidney allograft intimal arteritis: no association with markers of humoral rejection or with inferior outcome.

Authors:  Nicolas Kozakowski; Georg A Böhmig; Markus Exner; Afschin Soleiman; Nicole Huttary; Katalin Nagy-Bojarszky; Rupert C Ecker; Zeljko Kikić; Heinz Regele
Journal:  Nephrol Dial Transplant       Date:  2009-02-17       Impact factor: 5.992

7.  A Small Molecule β2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy.

Authors:  Samia Q Khan; Lingling Guo; David J Cimbaluk; Hatem Elshabrawy; Mohd Hafeez Faridi; Meenakshi Jolly; James F George; Anupam Agarwal; Vineet Gupta
Journal:  Front Med (Lausanne)       Date:  2014-11-12

Review 8.  M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection.

Authors:  Hanwen Zhang; Zhuonan Li; Wei Li
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.